Hiran Orgochem Ltd

Hiran Orgochem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Hiran Orgochem Ltd

₹ 0.48 4.35%
30 Mar 2015
Company website BSE: 506170
About

Hiran Orgochem is a leading integrated manufacturer of active pharmaceutical ingredients and formulations.

[ add key points ]
Website BSE
  • Market Cap ₹ Cr.
  • Current Price ₹ 0.48
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹ -6.23
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2015 Mar 2016 Jun 2016
0.00 0.00 0.00
0.00 0.12 0.06
Operating Profit 0.00 -0.12 -0.06
OPM %
0.00 0.93 0.00
Interest 0.00 0.06 0.00
Depreciation 0.00 0.01 0.01
Profit before tax 0.00 0.74 -0.07
Tax % 0.00% 0.00%
0.00 0.73 -0.07
EPS in Rs 0.00 0.07 -0.01
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: -1%
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

Annual reports

Credit ratings